Onkologie. 2016:10(3):150-154 | DOI: 10.36290/xon.2016.033

Fifteen years of Czech brest screening

Miroslava Skovajsová
BREAST UNIT PRAGUE, Mamma centrum Háje

In the Czech Republic a countrywide mammographic screening has been in function since 2003. Thus, 5 546 037 women have

been mammographically examined till the end of 2014 with 28 813 breast cancers detected, vast majority of them in early stages

with a good chance for effective therapy and excellent prognosis. In the years 2003–2009 regular and health insurance paid examinations

were available to women in age 45–69. Since 2010 mammographic screening has been extended beyond 69 years of

age with no upper limit. The participation of Czech women in mammographic screening exceeded 50 % already in 2008, in 2014

reached even 62,8 %. Effectiveness of screening, increasing proportion of early stages and reduction of breast cancer mortality

have been regularly audited and evaluated based on data collected from all 70 Czech breast cancer screening units.

Keywords: breast carcinoma, mammographic screening, participation of women in screening

Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skovajsová M. Fifteen years of Czech brest screening. Onkologie. 2016;10(3):150-154. doi: 10.36290/xon.2016.033.
Download citation

References

  1. Skovajsová M, Májek O, Daneš J, Bartoňková H, Ngo O, Dušek L. Výsledky Národního programu screeningu karcinomu prsu v České republice. Klinická onkologie 2014; 27(Suppl. 2): 69-78. Go to original source... Go to PubMed...
  2. Májek O, Bartoňková H, Daneš J, Skovajsová M, Dušek L. Implementace indikátorů kvality v programu screeningu karcinomu prsu: výsledky pravidelného monitoringu. Klinická onkologie 2014; 27(Suppl 2): 113-123. Go to original source... Go to PubMed...
  3. Májek O, Dušek L, Daneš J, Skovajsová M. Proč využíváme mamografii pro screening nádorů prsu a nepřestaneme ji využívat ani po vydání "aktuální" kanadské studie? Praktická gynekologie 2014; 18(1): 66-68.
  4. Májek O, Daneš J, Skovajsová M, Bartoňková H, Burešová L, Klimeš D, et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health 2011; 11: 288. Go to original source...
  5. Skovajsová M. Screening nádorů prsu v České republice. Praha: Maxdorf 2012. Edice Ambulantní gynekologie / sv. 2. ISBN 978-80-7345-310-7.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.